CT screening for lung cancer: significance of diagnoses in its baseline cycle.

[1]  K. Mori,et al.  Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. , 2002, The Journal of thoracic and cardiovascular surgery.

[2]  S Sone,et al.  High-resolution CT analysis of small peripheral lung adenocarcinomas revealed on screening helical CT. , 2001, AJR. American journal of roentgenology.

[3]  J S Spratt,et al.  Rates of growth of human neoplasms: Part II , 1996, Journal of surgical oncology.

[4]  Ali O. Farooqi,et al.  CT screening for lung cancer Assessing a regimen's diagnostic performance. , 2004, Clinical imaging.

[5]  Anthony P. Reeves,et al.  Three-dimensional segmentation and growth-rate estimation of small pulmonary nodules in helical CT images , 2003, IEEE Transactions on Medical Imaging.

[6]  K. Yasumoto,et al.  Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. , 2001, Radiology.

[7]  R. Gatenby,et al.  Models of tumor-host interaction as competing populations: implications for tumor biology and treatment. , 1995, Journal of theoretical biology.

[8]  Y. Inayama,et al.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. , 1995, The American journal of pathology.

[9]  Binsheng Zhao,et al.  Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. , 2000, Radiology.

[10]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[11]  William J Kostis,et al.  Overdiagnosis in chest radiographic screening for lung carcinoma , 2003, Cancer.

[12]  S. Friberg,et al.  On the growth rates of human malignant tumors: Implications for medical decision making , 1997, Journal of surgical oncology.

[13]  T. Naruke,et al.  Survival for clinical stage I lung cancer not surgically treated. Comparison between screen‐detected and symptom‐detected cases , 1992, Cancer.

[14]  O. Miettinen,et al.  CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. , 2002, AJR. American journal of roentgenology.

[15]  O. Miettinen,et al.  Screening for lung cancer: the early lung cancer action approach. , 2002, Lung cancer.

[16]  Y. Nishiwaki,et al.  Monoclonality of atypical adenomatous hyperplasia of the lung. , 1999, The American journal of pathology.

[17]  M. Melamed,et al.  The effect of surgical treatment on survival from early lung cancer. Implications for screening. , 1992, Chest.

[18]  O. Miettinen,et al.  Early lung cancer action project pathology protocol. , 2003, Lung cancer.

[19]  V. P. Collins,et al.  Differentiation of benign and malignant pulmonary nodules by growth rate. , 1962, Radiology.

[20]  K. Murase,et al.  Measurement of Localized Ground-Glass Attenuation on Thin-Section Computed Tomography Images: Correlation With the Progression of Bronchioloalveolar Carcinoma of the Lung , 2002, Investigative radiology.

[21]  A. Sakurada,et al.  Tumor doubling time and prognostic assessment of patients with primary lung cancer , 1994, Cancer.

[22]  C. Hill.  Bronchioloalveolar carcinoma: a review. , 1984, Radiology.

[23]  H Nakata,et al.  Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. , 2000, AJR. American journal of roentgenology.

[24]  Mordecai Schwartz.  A biomathematical approach to clinical tumor growth , 1961, Cancer.

[25]  Setsuo Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .

[26]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[27]  K Kuriyama,et al.  Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung. , 1999, AJR. American journal of roentgenology.

[28]  Ken Kodama,et al.  Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. , 2002, The Annals of thoracic surgery.

[29]  Simina C. Fluture,et al.  Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. , 2004, Radiology.

[30]  S. Sone,et al.  Prognostic significance of high-resolution CT findings in small peripheral adenocarcinoma of the lung: a retrospective study on 64 patients. , 2002, Lung cancer.

[31]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[32]  Yoshihiro Matsuno,et al.  Surgically Curable “Early” Adenocarcinoma in the Periphery of the Lung , 1994, The American journal of surgical pathology.

[33]  Rajiv Gupta,et al.  Small pulmonary nodules: evaluation with repeat CT--preliminary experience. , 1999, Radiology.

[34]  O. Miettinen,et al.  Small stage I cancers of the lung: genuineness and curability. , 2003, Lung cancer.

[35]  Y. Inayama,et al.  Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. , 1996, The American journal of surgical pathology.

[36]  J S Spratt,et al.  Rates of growth of human solid neoplasms: Part I , 1995, Journal of surgical oncology.

[37]  K Kuriyama,et al.  Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. , 2001, Lung cancer.